Staged Versus Simultaneous Bilateral Knee Arthroplasty

June 26, 2023 updated by: Orthopaedic Innovation Centre

Randomized Control Trial of Staged Versus Simultaneous Bilateral Total Knee Arthroplasty

The purpose of this study is to assist surgeons and patients in answering the question "Should I have both knees replaced at the same time, or should I just do one and wait to do the second one?"

Study Overview

Detailed Description

This is a multi-center randomized controlled trial of 224 patients in order to clearly delineate differences in post-operative outcomes and the trajectory of recovery between simultaneous and staged bilateral KA. The primary outcome measure is difference in generic health related quality of life between the two groups measured 1 year following surgery. Secondary outcome measures include differences in joint specific scores, time off work, satisfaction and costs.

This trial will inform patients and clinicians about differences in recovery, function and efficacy of the procedure to aid in the selection of treatment pathway to best suit the patient.

Study Type

Interventional

Enrollment (Estimated)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2P 3C5
        • University of Calgary
    • Manitoba
      • Winnipeg, Manitoba, Canada, R2K 3S8
        • Concordia Hospital
    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's - McMaster University
      • Kingston, Ontario, Canada, K7L 2V7
        • Kingston Health Sciences Center - KGH
      • London, Ontario, Canada, N6A 5W9
        • London Health Sciences Centre
      • Ottawa, Ontario, Canada, K1H 8L6
        • Ottawa Hospital Research Institute
      • Toronto, Ontario, Canada, M5B 1W8
        • St. Michael's Hospital
    • Quebec
      • Montréal, Quebec, Canada, H3A 0G4
        • McGill University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients considering bilateral knee arthroplasty
  • Patients must sign the consent form
  • Patients must be willing to complete the study questionnaires for the duration of the study

Exclusion Criteria:

  • Patients who require simultaneous bilateral knee replacement surgery in order to manage significant bilateral flexion or valgus knee contractures where staged procedures may result in suboptimal outcomes by increasing the risk of post-operative flexion contracture in the "first replaced" knee
  • patients who are unable to complete the questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Total Knee Arthroplasty (TKA)
Patient will have complete replacement - Simultaneous vs Staged
Patient will have both knees completed under one anesthetic.
Patient will have knees completed under 2 anesthetics.
Active Comparator: Unicompartmental Knee Arthroplasty (UKA)
Patient will have half-knee replacement (partial) - Simultaneous vs Staged
Patient will have both knees completed under one anesthetic.
Patient will have knees completed under 2 anesthetics.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Veterans Rand 12-item Health Survey Score (VR-12)
Time Frame: 1 Year
The VR-12 is a 12-item questionnaire corresponding to eight principal physical and mental health domains including general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy-fatigue, social functioning and mental health; patient-reported.
1 Year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Joint function (Oxford-12 knee score)
Time Frame: Pre-operative, 6 months, 12 months, 18 months, 24 months
The Oxford Knee Score (OKS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option (0-4). A total of the 12 items will indicated the joint function; lower total score = poorer function.
Pre-operative, 6 months, 12 months, 18 months, 24 months
Return to work
Time Frame: Pre-operative, 6 months, 12 months, 18 months, 24 months
Assessment of ability to return to work and time away from work following surgery.
Pre-operative, 6 months, 12 months, 18 months, 24 months
Patient satisfaction
Time Frame: 6 months, 12 months, 18 months, 24 months
Evaluate change in patient-reported satisfaction using a Likaert scale; 1=Very Satisfied to 5=Very Unsatisfied.
6 months, 12 months, 18 months, 24 months
Complications
Time Frame: Intraoperative, 6 months, 12 months, 18 months, 24 months
Evaluation type and frequency of complication (adverse events).
Intraoperative, 6 months, 12 months, 18 months, 24 months
Hospital stay
Time Frame: Up to 1 week
Number of days in hospital
Up to 1 week
Transfusion rate
Time Frame: Up to 1 week
Number of unit transfused during hospital stay.
Up to 1 week
Costs of knee replacement surgery
Time Frame: Up to 1 week
An attempt to calculate costs of surgery using length of stay data to calculate cost between Simultaneous vs Staged procedures. Length of stay will be calculated in days/hours.
Up to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eric R. Bohm, MD, University of Manitoba

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2018

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

June 11, 2018

First Submitted That Met QC Criteria

June 20, 2018

First Posted (Actual)

June 21, 2018

Study Record Updates

Last Update Posted (Actual)

June 27, 2023

Last Update Submitted That Met QC Criteria

June 26, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Simultaneous Knee Arthroplasty (UKA)

3
Subscribe